Cargando…
Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients
BACKGROUND: There is ongoing debate about the possible protective effect of the bivalent human papillomavirus (2vHPV) vaccine, targeting oncogenic types HPV-16/18, against anogenital warts (AGWs), commonly attributed to HPV-6/11. We performed a retrospective registry-based open cohort study to asses...
Autores principales: | Woestenberg, Petra J, Guevara Morel, Alejandra E, Bogaards, Johannes A, Hooiveld, Mariëtte, Schurink-van ‘t Klooster, Tessa M, Hoebe, Christian J P A, van der Sande, Marianne A B, van Benthem, Birgit H B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516515/ https://www.ncbi.nlm.nih.gov/pubmed/32421775 http://dx.doi.org/10.1093/cid/ciaa582 |
Ejemplares similares
-
Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019) -
Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
por: Woestenberg, Petra J, et al.
Publicado: (2018) -
Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
por: Schurink‐van ’t Klooster, Tessa M., et al.
Publicado: (2023) -
Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021) -
Determinants of high-risk human papillomavirus infection in anogenital warts
por: Ozaydin-Yavuz, Goknur, et al.
Publicado: (2019)